ACQUISITION OF GROUP C MEDICINES (CARDIOVASCULAR SYSTEM) FOR UNITS ADMINISTERED BY ZONAL COORDINATION 8 - HEALTH (09D06-CERI-APH)

This tender concerns the acquisition of Group C medicines, specifically those related to the cardiovascular system, for healthcare units managed by Zonal Coordination 8 - Health. The procurement process, identified by code SIE-CZ8S-2025-009-413592, aims to secure essential pharmaceutical supplies for the region. The primary item listed is Atenolol, an oral solid medication with a dosage of 50 mg, supplied in blister packs. The specified quantity for this item is one unit, with an estimated value of USD 43,474.91. The contracting entity is the COORDINACIÓN ZONAL 8 - SALUD, which is responsible for overseeing healthcare services within Zonal Coordination 8. The procurement method to be employed is Electronic Reverse Auction (Subasta Inversa Electrónica). This modality is typically used to obtain the best possible price through a competitive bidding process where suppliers progressively lower their offers. The tender is crucial for ensuring the continued availability of vital cardiovascular medications within the public health facilities under the purview of Zonal Coordination 8, thereby supporting patient treatment and care for cardiovascular conditions in the designated area.

This is a supplies contract in the governance and public administration sector. Located in Ecuador, Latin America, this opportunity is open to firms and consortiums, with an estimated budget of USD 43,475.

Published through SERCOP Ecuador, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the governance and public administration sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.